Business Description
OPKO Health Inc
NAICS : 339116
SIC : 2835
ISIN : US68375N1037
Description
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Opko's diagnostics business includes a core genetic testing operation. It has a development and commercial supply pharmaceutical company, as well as a world supply-chain operation and holding company in Ireland. It also owns a specialty active pharmaceutical ingredients manufacturer in Israel. It operates in two segments Diagnostics and Pharmaceuticals.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.79 | |||||
| Equity-to-Asset | 0.62 | |||||
| Debt-to-Equity | 0.37 | |||||
| Debt-to-EBITDA | 27.03 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -0.15 | |||||
| Beneish M-Score | -2.64 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -20 | |||||
| 3-Year Book Growth Rate | -10.3 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 44.48 | |||||
| 9-Day RSI | 48.36 | |||||
| 14-Day RSI | 50.22 | |||||
| 6-1 Month Momentum % | 20.9 | |||||
| 12-1 Month Momentum % | 1.75 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.97 | |||||
| Quick Ratio | 2.69 | |||||
| Cash Ratio | 1.92 | |||||
| Days Inventory | 42.96 | |||||
| Days Sales Outstanding | 57.88 | |||||
| Days Payable | 48.31 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -4.9 | |||||
| Shareholder Yield % | -0.75 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 25.1 | |||||
| Operating Margin % | -43.5 | |||||
| Net Margin % | -18.8 | |||||
| FCF Margin % | -27.99 | |||||
| ROE % | -9.71 | |||||
| ROA % | -6.51 | |||||
| ROIC % | -19.76 | |||||
| ROC (Joel Greenblatt) % | -39.37 | |||||
| ROCE % | -4.39 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.65 | |||||
| PB Ratio | 0.74 | |||||
| Price-to-Tangible-Book | 29.15 | |||||
| EV-to-EBIT | -13.91 | |||||
| EV-to-EBITDA | 59.54 | |||||
| EV-to-Revenue | 1.59 | |||||
| EV-to-Forward-Revenue | 1.64 | |||||
| EV-to-FCF | -5.64 | |||||
| Price-to-Projected-FCF | 5.83 | |||||
| Price-to-Median-PS-Value | 0.9 | |||||
| Earnings Yield (Greenblatt) % | -7.19 | |||||
| FCF Yield % | -19.56 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
OPKO Health Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 652.29 | ||
| EPS (TTM) (€) | -0.175 | ||
| Beta | 1.45 | ||
| Volatility % | 48.06 | ||
| 14-Day RSI | 50.22 | ||
| 14-Day ATR (€) | 0.040057 | ||
| 20-Day SMA (€) | 1.47526 | ||
| 12-1 Month Momentum % | 1.75 | ||
| 52-Week Range (€) | 0.7811 - 1.6 | ||
| Shares Outstanding (Mil) | 672.8 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
OPKO Health Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
OPKO Health Inc Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
OPKO Health Inc Frequently Asked Questions
What is OPKO Health Inc(STU:XCY)'s stock price today?
The current price of STU:XCY is €1.46. The 52 week high of STU:XCY is €1.60 and 52 week low is €0.78.
When is next earnings date of OPKO Health Inc(STU:XCY)?
The next earnings date of OPKO Health Inc(STU:XCY) is 2025-02-27 Est..
Does OPKO Health Inc(STU:XCY) pay dividends? If so, how much?
OPKO Health Inc(STU:XCY) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers